申请人:TAISHO PHARMACEUTICAL CO. LTD
公开号:EP0135249A1
公开(公告)日:1985-03-27
Novel styrene derivatives of the general formula
wherein
X is hydrogen or halogen, X' is halogen, R is hydrogen or methyl, and Y is hydroxymethyl, carboxyl, -COOR' or -COR2 (wherein R' is alkyl, substituted alkyl, prenyl, geranyl, farnesyl, cyclohexyl or phthalidyl, and R2 is amino, hydroxyamino, mono-(or di-)alkylamino, ethoxycarbonylmethylamino, carboxymethylamino, phenylamino, substituted phenylamino, thiazolylamino, cyclohexylamino, pyridylamino, morpholino or N-methyl- piperazino), and the pharmaceutically acceptable salts thereof when Y is carboxyl, exhibit high and long-lasting anti-inflammatory, analgesic and anti-pyretic activity.
通式如下的新型苯乙烯衍生物
其中
X是氢或卤素,X'是卤素,R是氢或甲基,Y是羟甲基、羧基、-COOR'或-COR2(其中R'是烷基、取代的烷基、炔基、香叶基、法呢基、环己基或邻苯二甲酰基,R2是氨基、羟基氨基、单(或二)烷基氨基、乙氧基羰基甲基氨基、苯基氨基、取代的苯基氨基、噻唑基氨基、环己基氨基、吡啶基氨基、羧甲基氨基、苯基氨基、取代的苯基氨基、噻唑基氨基、环己基氨基、吡啶基氨基)、当 Y 为羧基时)及其药学上可接受的盐类具有较高且持久的抗炎、镇痛和解热活性。